When discussing our primary antibodies for pain and neuroscience research, we always point to the 20+ years of results. Why wouldn't we? That's quite an accomplishment. Several of these antibodies have been consistently used in published research for over two decades. Over the weekend, two more studies were released using our antibodies in these familiar applications.
Image: Increased expression of mu opioid receptor levels in the ipsilateral lumbar DRGs of CPSS rats.
Researchers from Johns Hopkins University released pain research with the help of our rabbit Mu Opioid Receptor antibody (cat. RA10104). The paper introduced a rat model to study chronic pain after spine surgery (CPSS). By performing surgery on the rats and looking for symptoms of CPSS after the procedure, it provides a model to study the mechanisms of the disorder. You can read the full paper here.
In the second study, investigators from Osaka University and Seoul National University used our rabbit Alpha 2a Adrenergic Receptor antibody (cat. RA14110) to investigate anxiety, stress, and Alzheimer’s disease. The scientists explored how neurons of the locus coeruleus (LC) in mice reacted to added stress. They discovered the mechanisms of how chronic stress leads to the degeneration of LC neurons, which is linked to Alzheimer’s disease. Check out the full paper here.
We encourage you to explore our full selection of primary antibodies for pain and neuroscience research. Furthermore, all customer publications using our antibodies are here.
